About this trial
This prospective randomised clinical trial aims to assess the impact of intraoperative nociception monitoring using NOL on anesthetic management during major abdominal surgery. Additionally, the study will objectively evaluate using NOL how intravenous lidocaine administration, influences opioid requirements and the effect of this multimodal approach on early postoperative outcomes. The investigators hypothesize that NOL-guided intraoperative opioid administration reduces both intraoperative and postoperative opioid use, positively influencing 24-hour outcomes. Furthermore, the addition of intraoperative lidocaine in NOL-guided analgesia may further decrease opioid consumption.
Eligibility criteria
Qualifiers
age > 18 years
ASA score I-III
surgery for gastric or hepatobiliary or pancreatic neoplasia
Disqualifiers
pregnancy
lactation
neuraxial or regional anesthesia
chronic treatment with drugs that can influence autonomic nervous system
Trial design
Treatments tested in this trial
- Lidocaine Intravenous Infusion
- NOL
Treatment groups
Sponsors and collaborators
Osoian Cristiana
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Sponsor institution